[
DCMC Session
|
Presentation
]

Standardizing CMC Development Practices Across a Portfolio of Products | Digital CMC Basecamp On-Demand | Presentation

Explore how new technologies and advanced modalities have put CMC back in the drug development spotlight.

Discover how standardizing CMC practices can help contributors refocus on their most meaningful work.

Learn how an evolving CMC paradigm is shifting scientists’ day-to-day responsibilities and priorities.

Hear how drug developers can create a workplace optimized for current and future scientists.

CMC is a critical enabler of life-changing therapies again. See what that can mean for scientists.

As CMC programs becomes more data-centric and technologically enabled, scientists are feeling a fundamental shift in their work. New tools, changing workflows, and growing time-to-market pressure are all putting their skills to the test, and the future isn't slowing down for any discipline.

So at the Digital CMC Basecamp in Boston, we asked an important question: how can the industry design CMC programs that help keep their scientists engaged and inspired?

For an answer, we turned to a leading expert in digitizing technical development: Vijay Raju, VP CMC at Pioneering Medicines and Flagship Pioneering. In his keynote presentation, he dives into:

  • How drug developers can help CMC associates future-proof their knowledge, skills, and approach to data generation and curation
  • How organizations can evolve their CMC workflows to maximize scientists' focus on impactful activities and meaningful results
  • How Flagship Pioneering is putting those ideas into practice with centralized platform resources, capabilities, and intelligence for their portfolio companies

Sign up today to watch his full presentation and audience Q&A!

Session speakers

Watch this session

Legend
Legend
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

We’re here to help you deliver

No items found.
[
Flagship Pioneering
]

Vijay Raju

Vijay currently leads CMC activities to deliver on Pioneering Medicines portfolio. The portfolio is built on Flagship Pioneering's bio-platforms covering multiple modalities (small molecules, biologics, cell & gene therapies). Vijay was previously in technical leadership roles at Novartis.